相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacology of bisphosphonates in pain
Thomas M. Tzschentke
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Oxtr/TRPV1 expression and acclimation of skeletal muscle to cold-stress in male mice
Elena Conte et al.
JOURNAL OF ENDOCRINOLOGY (2021)
Consequences of SUR2[A478V] Mutation in Skeletal Muscle of Murine Model of Cantu Syndrome
Rosa Scala et al.
CELLS (2021)
Zoledronic Acid as a Novel Dual Blocker of KIR6.1/2-SUR2 Subunits of ATP-Sensitive K+ Channels: Role in the Adverse Drug Reactions
Fatima Maqoud et al.
PHARMACEUTICS (2021)
Bisphosphonates-much more than only drugs for bone diseases
Anna Kuznik et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Glibenclamide reverses cardiovascular abnormalities of Cantu syndrome driven by KATP channel overactivity Conor
Conor McClenaghan et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Zoledronic Acid Activates TRPV1 Channels: Possible Role in Cell Proliferation and Pain
Rosa Scala et al.
FASEB JOURNAL (2020)
Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates
Dennis M. Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Pathophysiological Consequences of KATP Channel Overactivity and Pharmacological Response to Glibenclamide in Skeletal Muscle of a Murine Model of Cantu Syndrome
Rosa Scala et al.
FRONTIERS IN PHARMACOLOGY (2020)
Zoledronic Acid Modulation of TRPV1 Channel Currents in Osteoblast Cell Line and Native Rat and Mouse Bone Marrow-Derived Osteoblasts: Cell Proliferation and Mineralization Effect
Rosa Scala et al.
CANCERS (2019)
Glibenclamide treatment in a Cantu syndrome patient with a pathogenic ABCC9 gain-of-function variant: Initial experience
Alan Ma et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2019)
Alendronate induces osteoclast precursor apoptosis via peroxisomal dysfunction mediated ER stress
Ning Ding et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Novel bisphosphonates with antiresorptive effect in bone mineralization and osteoclastogenesis
Salvatore Savino et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Cell Cycle Regulation by Ca2+-Activated K+ (BK) Channels Modulators in SH-SY5Y Neuroblastoma Cells
Fatima Maqoud et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Cardiovascular consequences of KATP overactivity in Cantu syndrome
Yan Huang et al.
JCI INSIGHT (2018)
Regional Osteoporosis Due to Osteoclast Activation as a Trigger for the Pain-Like Behaviors in Tail-Suspended Mice
Takayuki Dohke et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2017)
The Bisphosphonates Clodronate and Etidronate Exert Analgesic Effects by Acting on Glutamate- and/or ATP-Related Pain Transmission Pathways
Kazuhiro Shima et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2016)
Targeting Cancer Cells with a Bisphosphonate Prodrug
Kenji Matsumoto et al.
CHEMMEDCHEM (2016)
Alendronate Attenuates Spinal Microglial Activation and Neuropathic Pain
Yao Yao et al.
JOURNAL OF PAIN (2016)
Hydroxyapatite nanocrystals functionalized with alendronate as bioactive components for bone implant coatings to decrease osteoclastic activity
Ruggero Bosco et al.
APPLIED SURFACE SCIENCE (2015)
Dual response of the KATP channels to staurosporine: A novel role of SUR2B, SUR1 and Kir6.2 subunits in the regulation of the atrophy in different skeletal muscle phenotypes
Antonietta Mele et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Database search of spontaneous reports and pharmacological investigations on the sulfonylureas and glinides-induced atrophy in skeletal muscle
Antonietta Mele et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2014)
Effects of the Antidiabetic Drugs on the Age-Related Atrophy and Sarcopenia Associated with Diabetes Type II
Michela Cetrone et al.
CURRENT DIABETES REVIEWS (2014)
KATP Channels and Cardiovascular Disease Suddenly a Syndrome
Colin G. Nichols et al.
CIRCULATION RESEARCH (2013)
Purinergic mechanisms and pain-An update
Geoffrey Burnstock
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Analgesic effects of the non-nitrogen-containing bisphosphonates etidronate and clodronate, independent of anti-resorptive effects on bone
Siyoung Kim et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
The effects of zoledronic acid in the bone and vasculature support of hematopoietic stem cell niches
Fabiana N. Soki et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Basic research and clinical applications of bisphosphonates in bone disease: what have we learned over the last 40 years?
Xiao-Long Xu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
The effect of alendronate doped calcium phosphates on bone cells activity
Elisa Boanini et al.
BONE (2012)
Nociceptive and pro-inflammatory effects of dimethylallyl pyrophosphate via TRPV4 activation
S. Bang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Dominant missense mutations in ABCC9 cause Cantu syndrome
Magdalena Harakalova et al.
NATURE GENETICS (2012)
Splicing of the rSlo Gene Affects the Molecular Composition and Drug Response of Ca2+-Activated K+ Channels in Skeletal Muscle
Maria Maddalena Dinardo et al.
PLOS ONE (2012)
Opening/blocking actions of pyruvate kinase antibodies on neuronal and muscular KATP channels
Antonietta Mele et al.
PHARMACOLOGICAL RESEARCH (2012)
Bisphosphonates in preclinical bone oncology
Philippe Clezardin et al.
BONE (2011)
Novel actions of bisphosphonates in bone: Preservation of osteoblast and osteocyte viability
Teresita Bellido et al.
BONE (2011)
Bisphosphonates: The first 40 years
R. Graham G. Russell
BONE (2011)
Bisphosphonates' antitumor activity: An unravelled side of a multifaceted drug class
Philippe Clezardin
BONE (2011)
Determination of zoledronic acid in human urine and blood plasma using liquid chromatography/electrospray mass spectrometry
Katrin Veldboer et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2011)
Differences Between Bisphosphonates in Binding Affinities for Hydroxyapatite
M. A. Lawson et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS (2010)
The KATP channel is a molecular sensor of atrophy in skeletal muscle
Domenico Tricarico et al.
JOURNAL OF PHYSIOLOGY-LONDON (2010)
Adverse Effects of Bisphosphonates: Implications for Osteoporosis Management
Kurt A. Kennel et al.
MAYO CLINIC PROCEEDINGS (2009)
Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
Michael Gnant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Functions of RANKL/RANK/OPG in bone modeling and remodeling
Brendan F. Boyce et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2008)
Intravenous ibandronate rapidly reduces pain, neurochemical indices of central sensitization, tumor burden, and skeletal destruction in a mouse model of bone cancer
Kyle G. Halvorson et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2008)
Adsorption and conformational change of myoglobin on biomimetic hydroxyapatite nanocrystals functionalized with alendronate
Michele Iafisco et al.
LANGMUIR (2008)
Bisphosphonates: Mechanism of action and role in clinical practice
Mathew T. Drake et al.
MAYO CLINIC PROCEEDINGS (2008)
More on Atypical Fractures of the Femoral Diaphysis
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
R. G. G. Russell et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure
Robert R. Recker et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading
Helene Follet et al.
BONE (2007)
In vitro comparison of clodronate, pamidronate and zoledronic acid effects on rat osteoclasts and human stem cell-derived osteoblasts
M Kellinsalmi et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2005)
Severely suppressed bone turnover: A potential complication of alendronate therapy
CV Odvina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Mesenchymal stem cells - Lineage, plasticity, and skeletal therapeutic potential
Richard O. C. Oreffo et al.
STEM CELL REVIEWS (2005)
Highly potent geminal bisphosphonates.: From pamidronate disodium (Aredia) to zoledronic acid (Zometa)
L Widler et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Transduction of cell survival signals by connexin-43 hemichannels
LI Plotkin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A pharmacokinetic and pharmacodynamic model for intravenous bisphosphonate (pamidronate) in osteoporosis
S Cremers et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts
V Viereck et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
分享论文
